-
1 Comment
Mayinglong Pharmaceutical Group Co., LTD is currently in a long term uptrend where the price is trading 26.0% above its 200 day moving average.
From a valuation standpoint, the stock is 70.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.8.
Mayinglong Pharmaceutical Group Co., LTD's total revenue rose by 35.0% to $1B since the same quarter in the previous year.
Its net income has increased by 34.2% to $90M since the same quarter in the previous year.
Finally, its free cash flow fell by 118.6% to $-65M since the same quarter in the previous year.
Based on the above factors, Mayinglong Pharmaceutical Group Co., LTD gets an overall score of 4/5.
| CurrencyCode | CNY |
|---|---|
| ISIN | CNE000001HN2 |
| Exchange | SHG |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Beta | 0.55 |
|---|---|
| Market Cap | 11B |
| PE Ratio | 21.36 |
| Target Price | 20.45 |
| Dividend Yield | None |
Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the manufacturing and sale of Chinese and Western medicines primarily in China. The company provides functional cosmetics, such as eye care, eye daily necessities, facial and body cleaning, and care products; functional care products include infant paper, infant skin care, feminine products, etc.; functional foods, including moisturizing the intestines, promoting digestion, and nourishing the kidneys. It also offers foundation and dietary supplements; medical products comprising anorectal postoperative care, daily electronic auxiliary products, eye device care, disinfection and sterilization, etc. In addition, the company is involved in the development, production, and sale of pharmaceutical products; retail and wholesale of medical devices and drugs; provision of hospital medical and management service; and hospital operations. It sells its products through online stores. Mayinglong Pharmaceutical Group Co., Ltd., was founded in 1582 and is headquartered in Wuhan, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600993.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
